JP Morgan Maintains Neutral on Incyte, Raises Price Target to $61
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Jessica Fye maintains a Neutral rating on Incyte (NASDAQ:INCY) and raises the price target from $59 to $61.
July 31, 2024 | 4:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan analyst Jessica Fye maintains a Neutral rating on Incyte and raises the price target from $59 to $61.
The raised price target from $59 to $61 indicates a positive outlook, which could lead to a slight increase in investor confidence and a potential short-term price uptick.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100